NASDAQ:PIII P3 Health Partners (PIII) Stock Price, News & Analysis $0.39 +0.01 (+2.62%) (As of 09/27/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get P3 Health Partners alerts: Email Address About P3 Health Partners Stock (NASDAQ:PIII) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get P3 Health Partners alerts:Sign Up Key Stats Today's Range$0.38▼$0.4150-Day Range$0.38▼$0.6352-Week Range$0.35▼$1.93Volume69,036 shsAverage Volume406,995 shsMarket Capitalization$123.92 millionP/E RatioN/ADividend YieldN/APrice Target$4.50Consensus RatingModerate Buy Company OverviewP3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.Read More… The True Potential for Civil War… (Ad)Radical leftists mobilizing illegal immigrants, violence and looting, even marital law. 43% of respondents, for example, in a recent survey said they believe a civil war is “likely” in the next decade.Click here. P3 Health Partners Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks67th Percentile Overall ScorePIII MarketRank™: P3 Health Partners scored higher than 67% of companies evaluated by MarketBeat, and ranked 379th out of 995 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingP3 Health Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageP3 Health Partners has received no research coverage in the past 90 days.Read more about P3 Health Partners' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for P3 Health Partners are expected to decrease in the coming year, from ($0.23) to ($0.25) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of P3 Health Partners is -0.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of P3 Health Partners is -0.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioP3 Health Partners has a P/B Ratio of 0.87. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about P3 Health Partners' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.67% of the float of P3 Health Partners has been sold short.Short Interest Ratio / Days to CoverP3 Health Partners has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in P3 Health Partners has recently decreased by 6.40%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldP3 Health Partners does not currently pay a dividend.Dividend GrowthP3 Health Partners does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.67% of the float of P3 Health Partners has been sold short.Short Interest Ratio / Days to CoverP3 Health Partners has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in P3 Health Partners has recently decreased by 6.40%, indicating that investor sentiment is improving significantly. News and Social Media1.9 / 5News Sentiment0.46 News SentimentP3 Health Partners has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for P3 Health Partners this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for PIII on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added P3 Health Partners to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, P3 Health Partners insiders have bought more of their company's stock than they have sold. Specifically, they have bought $205,600.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders17.86% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 7.75% of the stock of P3 Health Partners is held by institutions.Read more about P3 Health Partners' insider trading history. Receive PIII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address PIII Stock News HeadlinesPacific Founders Ugp I. Chicago Acquires 80,000 Shares of P3 Health Partners Inc. (NASDAQ:PIII) StockSeptember 16, 2024 | insidertrades.comP3 Health Partners Inc. (NASDAQ:PIII) Major Shareholder Pacific Founders Ugp I. Chicago Purchases 80,000 SharesSeptember 14, 2024 | insidertrades.comHow a $200,000 Mistake Unlocked a $118 Billion Gold TreasureThe window of opportunity on this gold stock is closing fast. Once word gets out, it may be too late.September 28, 2024 | Monument Traders Alliance (Ad)Insider Buying: P3 Health Partners Inc. (NASDAQ:PIII) Major Shareholder Buys 80,000 Shares of StockSeptember 13, 2024 | insidertrades.comP3 Health Partners (PIII) Gets a Buy from Lake StreetSeptember 5, 2024 | markets.businessinsider.comP3 Health Partners Names Leif Pedersen New Chief Financial OfficerAugust 30, 2024 | finance.yahoo.comP3 Health Partners Inc.'s (NASDAQ:PIII) market cap dropped US$9.5m last week; Private equity firms bore the bruntAugust 26, 2024 | finance.yahoo.comP3 Health Partners Schedules Second Quarter 2024 Earnings Release and Conference CallJuly 24, 2024 | finance.yahoo.comSee More Headlines PIII Stock Analysis - Frequently Asked Questions How have PIII shares performed this year? P3 Health Partners' stock was trading at $1.41 at the beginning of 2024. Since then, PIII shares have decreased by 72.2% and is now trading at $0.3920. View the best growth stocks for 2024 here. How were P3 Health Partners' earnings last quarter? P3 Health Partners Inc. (NASDAQ:PIII) posted its quarterly earnings data on Wednesday, August, 7th. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of ($0.08) by $0.07. The business had revenue of $379.16 million for the quarter, compared to analyst estimates of $364.50 million. P3 Health Partners had a negative net margin of 4.95% and a negative trailing twelve-month return on equity of 43.19%. Who are P3 Health Partners' major shareholders? Top institutional shareholders of P3 Health Partners include Armistice Capital LLC (2.50%), Emfo LLC (0.45%), Sanders Morris Harris LLC (0.05%) and Renaissance Technologies LLC (0.04%). Insiders that own company stock include Pacific Founders Ugp Chicago, Pacific Founders Ugp I Chicago, Sherif Abdou, Atul Kavthekar and Michael Balkin. View institutional ownership trends. How do I buy shares of P3 Health Partners? Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Company Calendar Last Earnings8/07/2024Today9/27/2024Next Earnings (Estimated)11/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryHealthcare Current SymbolNASDAQ:PIII CUSIPN/A CIK1832511 Webforesightacq.com Phone702-910-3950FaxN/AEmployees500Year FoundedN/APrice Target and Rating Average Stock Price Target$4.50 High Stock Price Target$4.50 Low Stock Price Target$4.50 Potential Upside/Downside+1,048.0%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-57,770,000.00 Net Margins-4.95% Pretax Margin-12.80% Return on Equity-43.19% Return on Assets-7.93% Debt Debt-to-Equity Ratio0.80 Current Ratio0.69 Quick Ratio0.69 Sales & Book Value Annual Sales$1.40 billion Price / Sales0.09 Cash Flow$0.09 per share Price / Cash Flow4.14 Book Value$0.45 per share Price / Book0.87Miscellaneous Outstanding Shares316,115,000Free Float259,657,000Market Cap$123.92 million OptionableNot Optionable Beta1.17 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report This page (NASDAQ:PIII) was last updated on 9/28/2024 by MarketBeat.com Staff From Our PartnersFed Triggers Boom: Buy this Play on Elon’s New AIHave you seen Elon Musk's new invention? I was already very bullish on this new type of AI. And now that...InvestorPlace | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | Sponsored10X More Profitable Than Physical Gold?The smart money is piling into gold and gold stocks. There's a backdoor gold play that could deliver 10 TIM...Monument Traders Alliance | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredThe most serious warning of my careerWith the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the ...Porter & Company | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored50-Yr Wall Street Legend: “Sell this AI stock NOW”Nearly 1 million people around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly ...Chaikin Analytics | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share P3 Health Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.